Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP1 decreases the amount of CDT1. 1 / 1

| 1

➶

reach

"It is important to note that USP1 depletion neither reduced the steady-state level of another known DDB1 target, chromatin licensing and DNA replication factor 1 (CDT1), nor enhanced its DNA damage induced degradation, suggesting that the DDB1 and CUL4A machinery is not simply overactive in USP1 depleted cells."

21389083

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...